Anti-PD-1 clinical trials

A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors

This study is testing a new medicine, CRB-701, for people with certain advanced solid cancers. It aims to find a safe and effective dose, and see which cancers it can treat. Participants will receive the medicine and have tests to check how it works.